🔎 Trials Near Me

Gara Jalqabaatti › Dukkana Dhiigaa › Washington

Qorannoo klinikaalii Dukkana Dhiigaa Washington keessatti

Qorannoo 20 Dukkana Dhiigaa f Washington keessatti hirmaatuu jiru.

Magaalota Washington keessatti

Takkalaa qorannoo (Ingiliffa)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

  • Fred Hutchinson Cancer Center ( Site 0024), Bellevue
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03486873

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Providence Regional Cancer System-Aberdeen, Aberdeen
  • PeaceHealth Saint Joseph Medical Center, Bellingham
  • Providence Regional Cancer System-Centralia, Centralia
  • fi 19 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

  • Fred Hutchinson Cancer Research Center, Seattle
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06697184

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

  • Medical Oncology Associates (Summit Cancer Centers) ( Site 2710), Spokane
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT04728893

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  • Fred Hutchinson Cancer Research Center, Seattle
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07648264

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • Providence Regional Cancer System-Aberdeen, Aberdeen
  • PeaceHealth Saint Joseph Medical Center, Bellingham
  • Providence Regional Cancer System-Centralia, Centralia
  • fi 18 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04242095

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • University of Washington, Seattle
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06001788

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT04515810

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

  • Fred Hutchinson Cancer Center, Seattle
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT06665100

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Fred Hutchinson Cancer Research Center, Seattle
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

IVIG for Infection Prevention After CAR-T-Cell Therapy

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT05952804

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT03670966

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

  • Seattle Childrens Hospital, Seattle
Namoota walitti qabaa jiraQorannoo ilaalaa
Hanga umuriin 30 · Saalaa hunda · Haaromfame 18-Wax-2026 · NCT06579469

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • University of Washington Medical Center, Seattle
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT03328078

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

  • Fred Hutchinson Cancer Centre, Seattle
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT06510699

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

  • Swedish Cancer Institute, Seattle
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2025 · NCT05768269

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

  • University of Washington, Seattle
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Elb-2025 · NCT05956457

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Fred Hutchinson Cancer Center, Seattle
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Seattle Children's Hospital, Seattle
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

  • Fred Hutchinson Cancer Center, Seattle
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Sad-2024 · NCT06034275

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.